- United States
- Canada
- Norway
About
Regeneron Ventures is the strategic corporate venture capital fund of Regeneron. The firm invests in and supports innovative companies with disruptive technologies in the biopharmaceutical, healthcare, and health technology sectors. Their mission is to advance science and improve human health by leveraging Regeneron's extensive resources and expertise.
Regeneron Ventures is the corporate venture capital arm of Regeneron, investing in biopharmaceutical, healthcare, and health technology companies. They are stage-agnostic, seeking disruptive technologies with the potential to transform the practice of medicine and improve human health. Their unique value proposition is providing portfolio companies with access to Regeneron's deep scientific, clinical, and business expertise to accelerate growth and innovation.
The leadership team, including the Head of Regeneron Ventures, brings extensive experience from senior roles in healthcare investment banking, venture capital, and corporate development at major firms like J.P. Morgan, T. Rowe Price, and Merck. The team combines deep scientific expertise with a strong track record in biopharmaceutical business development and strategic investment. Their collective background is rooted in identifying and nurturing early-stage companies with innovative technologies.